共 50 条
- [2] Selegiline in Parkinson's disease - No neuroprotective effect: Increased mortality BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7020): : 1583 - 1584
- [3] Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson’s disease: a meta-analysis Aging Clinical and Experimental Research, 2020, 32 : 769 - 779
- [5] Effect of adding selegiline to levodopa in early, mild Parkinson's disease - Other studies have not shown increased mortality BRITISH MEDICAL JOURNAL, 1996, 312 (7032): : 702 - 702
- [7] Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease BRITISH MEDICAL JOURNAL, 1995, 311 (7020): : 1602 - 1607
- [8] Effect of adding selegiline to levodopa in early, mild Parkinson's disease - Selegiline may be toxic in presence of increased dopamine concentrations BRITISH MEDICAL JOURNAL, 1996, 312 (7032): : 703 - 704
- [10] Effect of adding selegiline to levodopa in early, mild Parkinson's disease -: Evidence is insufficient to show that combined treatment increases mortality BRITISH MEDICAL JOURNAL, 1998, 317 (7172): : 1586 - 1587